Garvan Research Opportunity Funded!

Research Funding Oportunity Design - slider 27730

Thanks to the generosity of our wonderful community we have reached the target and this strategic, internationally competitive and non-redundant research will commence without delay. We look forward to keeping you up to date with the outcomes of this project and other research news as it becomes available.

Of course our efforts do not stop with this project. Since Shake It Up was established in 2011 we have committed over $1.1M to Australian Parkinson’s research and whilst this is moving us closer to our goal we need to keep the momentum going. We need others to join our quest for better treatments and ultimately a cure and as one of our valued supporters we hope you continue to share our goals with your family, friends and colleagues.

THE PROJECT

  • Finding biological markers (biomarkers) for Parkinson’s is a critical step for achieving early diagnosis, monitoring disease progression and assessing more effective treatments.

  • Through funding from Shake It Up and the Michael J. Fox Foundation, The Garvan Institute for Medical Research has been researching the role of RNAs in Parkinson’s and they would now like to use that research to investigate whether a specific RNA molecule, from a gene region with a high link to sporadic Parkinson’s, can serve as a biomarker to diagnosis the disease. Click here to read an overview of this project in layman’s terms!

  • The Michael J. Fox Foundation has approved a $55,460 grant for The Garvan to undertake this research and has also committed 50% of the funds.

  • The remaining 50% ($27,730) is to come from Shake It Up Australia Foundation and through your amazing support we have raised these funds.

Anthony Cooper - Garvan Institute

‘We are undertaking a range of approaches to identify the early changes occurring in the brains of patients. This will allow us to target therapies to stop the earliest phases of the disease before symptoms appear and so prevent the subsequent cascade of symptoms that follow.’

– Dr Antony Cooper, Garvan Institute

 

 

 

Garvan_Institute_of_Medical_Research_Logo

Print